Annual ROE
14.66%
-6.50%-30.72%
December 31, 2023
Summary
- As of February 12, 2025, GMAB annual return on equity is 14.66%, with the most recent change of -6.50% (-30.72%) on December 31, 2023.
- During the last 3 years, GMAB annual ROE has fallen by -13.03% (-47.06%).
- GMAB annual ROE is now -50.27% below its all-time high of 29.48%, reached on December 31, 2016.
Performance
GMAB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
14.86%
-3.07%-17.12%
September 1, 2024
Summary
- As of February 12, 2025, GMAB quarterly return on equity is 14.86%, with the most recent change of -3.07% (-17.12%) on September 1, 2024.
- Over the past year, GMAB quarterly ROE has dropped by -0.20% (-1.33%).
- GMAB quarterly ROE is now -64.40% below its all-time high of 41.74%, reached on June 30, 2020.
Performance
GMAB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
GMAB ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -30.7% | -1.3% |
3 y3 years | -47.1% | -24.7% |
5 y5 years | -29.6% | -24.7% |
GMAB ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -30.7% | +1.9% | -36.0% | +35.2% |
5 y | 5-year | -47.1% | +1.9% | -64.4% | +35.2% |
alltime | all time | -50.3% | +113.3% | -64.4% | +112.7% |
Genmab A/S ROE History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | 14.86%(-17.1%) |
Jun 2024 | - | 17.93%(-1.1%) |
Mar 2024 | - | 18.13%(+21.3%) |
Dec 2023 | 14.66%(-30.7%) | 14.95%(-0.7%) |
Sep 2023 | - | 15.06%(-11.0%) |
Jun 2023 | - | 16.93%(-14.2%) |
Mar 2023 | - | 19.73%(-8.4%) |
Dec 2022 | 21.16%(+47.0%) | 21.53%(-7.3%) |
Sep 2022 | - | 23.22%(+33.4%) |
Jun 2022 | - | 17.40%(+58.3%) |
Mar 2022 | - | 10.99%(-24.0%) |
Dec 2021 | 14.39%(-48.0%) | 14.47%(-0.9%) |
Sep 2021 | - | 14.60%(+9.8%) |
Jun 2021 | - | 13.30%(-56.1%) |
Mar 2021 | - | 30.32%(+10.3%) |
Dec 2020 | 27.69%(+42.1%) | 27.49%(-23.6%) |
Sep 2020 | - | 35.97%(-13.8%) |
Jun 2020 | - | 41.74%(+103.5%) |
Mar 2020 | - | 20.51%(-2.5%) |
Dec 2019 | 19.48%(-6.5%) | 21.04%(+21.0%) |
Sep 2019 | - | 17.39%(+14.1%) |
Jun 2019 | - | 15.24%(-16.6%) |
Mar 2019 | - | 18.28%(-12.8%) |
Dec 2018 | 20.83%(+5.2%) | 20.97%(-5.4%) |
Sep 2018 | - | 22.16%(+8.7%) |
Jun 2018 | - | 20.39%(-8.8%) |
Mar 2018 | - | 22.36%(+7.6%) |
Dec 2017 | 19.80%(-32.8%) | 20.79%(-8.9%) |
Sep 2017 | - | 22.82%(-21.8%) |
Jun 2017 | - | 29.17%(+1.3%) |
Mar 2017 | - | 28.80%(-4.6%) |
Dec 2016 | 29.48% | 30.19%(+46.8%) |
Sep 2016 | - | 20.56%(+0.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2016 | - | 20.52%(+19.7%) |
Mar 2016 | - | 17.15%(-36.7%) |
Dec 2015 | 26.96%(+13.9%) | 27.08%(+52.6%) |
Sep 2015 | - | 17.74%(-16.5%) |
Jun 2015 | - | 21.25%(+4.9%) |
Mar 2015 | - | 20.25%(+8.6%) |
Dec 2014 | 23.67%(+12.4%) | 18.65%(-15.7%) |
Sep 2014 | - | 22.12%(+66.6%) |
Jun 2014 | - | 13.28%(-26.1%) |
Mar 2014 | - | 17.96%(-19.6%) |
Dec 2013 | 21.06%(-119.1%) | 22.34%(-133.2%) |
Sep 2013 | - | -67.34%(-21.2%) |
Jun 2013 | - | -85.46%(+3.9%) |
Mar 2013 | - | -82.24%(-29.5%) |
Dec 2012 | -110.19%(+37.2%) | -116.65%(+205.8%) |
Sep 2012 | - | -38.14%(-57.2%) |
Jun 2012 | - | -89.13%(+4.6%) |
Mar 2012 | - | -85.23%(+10.4%) |
Dec 2011 | -80.31%(+210.3%) | -77.21%(+10.0%) |
Sep 2011 | - | -70.21%(+145.7%) |
Jun 2011 | - | -28.58%(+5.9%) |
Mar 2011 | - | -26.98%(-0.3%) |
Dec 2010 | -25.88%(-54.8%) | -27.05%(-63.7%) |
Sep 2010 | - | -74.42%(-6.6%) |
Jun 2010 | - | -79.64%(+2.2%) |
Mar 2010 | - | -77.90%(+0.4%) |
Dec 2009 | -57.30%(+46.8%) | -77.60% |
Dec 2008 | -39.02%(+134.8%) | - |
Dec 2007 | -16.62%(-48.0%) | - |
Dec 2006 | -31.96%(-4.6%) | - |
Dec 2005 | -33.50%(-3.8%) | - |
Dec 2004 | -34.83%(+33.3%) | - |
Dec 2003 | -26.12%(-15.4%) | - |
Dec 2002 | -30.88% | - |
FAQ
- What is Genmab A/S annual return on equity?
- What is the all time high annual ROE for Genmab A/S?
- What is Genmab A/S annual ROE year-on-year change?
- What is Genmab A/S quarterly return on equity?
- What is the all time high quarterly ROE for Genmab A/S?
- What is Genmab A/S quarterly ROE year-on-year change?
What is Genmab A/S annual return on equity?
The current annual ROE of GMAB is 14.66%
What is the all time high annual ROE for Genmab A/S?
Genmab A/S all-time high annual return on equity is 29.48%
What is Genmab A/S annual ROE year-on-year change?
Over the past year, GMAB annual return on equity has changed by -6.50% (-30.72%)
What is Genmab A/S quarterly return on equity?
The current quarterly ROE of GMAB is 14.86%
What is the all time high quarterly ROE for Genmab A/S?
Genmab A/S all-time high quarterly return on equity is 41.74%
What is Genmab A/S quarterly ROE year-on-year change?
Over the past year, GMAB quarterly return on equity has changed by -0.20% (-1.33%)